p53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors.

MLA

Yamamoto, Mitsugu, et al. “P53 Accumulation Is a Strong Predictor of Recurrence in Estrogen Receptor-Positive Breast Cancer Patients Treated with Aromatase Inhibitors.” Cancer Science, vol. 105, no. 1, Jan. 2014, pp. 81–88. EBSCOhost, https://doi.org/10.1111/cas.12302.

APA

Yamamoto, M., Hosoda, M., Nakano, K., Jia, S., Hatanaka, K. C., Takakuwa, E., Hatanaka, Y., Matsuno, Y., & Yamashita, H. (2014). p53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors. Cancer Science, 105(1), 81–88. https://doi.org/10.1111/cas.12302

Chicago

Yamamoto, Mitsugu, Mitsuchika Hosoda, Kiichiroh Nakano, Shusheng Jia, Kanako C. Hatanaka, Emi Takakuwa, Yutaka Hatanaka, Yoshihiro Matsuno, and Hiroko Yamashita. 2014. “P53 Accumulation Is a Strong Predictor of Recurrence in Estrogen Receptor-Positive Breast Cancer Patients Treated with Aromatase Inhibitors.” Cancer Science 105 (1): 81–88. doi:10.1111/cas.12302.